Day Three (15th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
- Karen Wohlers - Scientist Bioprocessing Development, Bluu Seafood
- A Representative - |, Novartis
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Zahra Rattray - Senior Lecturer, Strathclyde Institute of Pharmacy and Biomedical Sciences
- Stephane Busso - CLD Scientist, Biopharmaceutical Product Development, Fresenius Kabi
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Julia Müller - PhD Student, University of Applied Sciences and Arts Northwestern Switzerland
- Michel Eppink - Senior Director - Downstream Processing, Byondis B.V.
- Transformation and Innovation: Takeda's strategic shift towards innovative therapies and advanced manufacturing modalities.
- Supply Chain Resilience: Ensuring a resilient, agile, and sustainable global supply chain to deliver life-saving therapies.
- Digital Integration: Utilizing IoT for real-time visibility and AI for intelligent decision-making to enhance efficiency and reduce time-to-market.
- Vighnesh Balan - Global Supply Chain Business Excellence Lead, Takeda
- Ulrich Rümenapp - Senior Biotech Program Lead, Bayer AG
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Omkar Kawalekar - Co-Founder, BlueWhale
- Andrew Harmon, MBA - Senior Consultant, Strategic Consulting, Latham BioPharm Group
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Lenny Zaffaroni, PhD - Senior Scientist, Bavarian Nordic
- Deborah Hol-Schop - Principal Scientist Upstream Processes, Byondis
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Niall Barron - Principal Investigator, NIBRT
- Lekan Daramola - Consultant, Freelance
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Sofia Carvalho - Senior Scientist, iBET
The applications of computational tools such as Artificial Intelligence and Predictive Modelling within the purification process
Bridging the gap between academia and industry in AI and Predictive Modelling adoption
Chromatography optimization
Reduction of manual tests to lower costs
Accelerating time to market with AI tools
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
How CDMOs have evolved in the last 5 years and what to expect in the coming years
Geopolitical uncertainty and its impact on outsourced manufacturing
Collaboration to understand the changing needs of pharma and biotech
- Ulrich Rümenapp - Senior Biotech Program Lead, Bayer AG
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
While cell therapies have demonstrated exceptional efficacy, patient access and COGs continue to present major concerns. Achieving transformative improvements in cell therapy manufacturability will require access to larger data set analyses than any one therapy developer can accomplish, except through years of accumulated data - years, during which confidence in the sector will continue to erode. By increasing the size of the data set, data sharing across therapy developers can lead to faster, reliable identification of parameters key to manufacturability. A precompetitive collaboration that leverages the entire Vein-to-Vein Data Ecosystem to enable optimization of manufacturing, donor selection, and patient stratification can deliver disruptive innovation and accelerate maturation of the sector.
- Kat Kozyrytska - Independent Consultant, Kozyrytska Consulting
- Tiffany Rau, PhD - Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: Partners@informaconnectls.com
- Verena Fischer - Lab Head Early Stage Upstream Development, Boehringer Ingelheim
This panel discussion will bring together experts from both upstream and downstream teams to discuss the challenges and opportunities in integrating these two critical stages of biomanufacturing. The conversation will focus on the harvest step as a key point of integration, exploring how upstream activities can influence downstream purification processes. Panellists will share insights on their limitations, expectations, and strategies for improving collaboration to reduce costs, optimize timelines, and enhance overall production efficiency.
- Thomas Jostock, PhD - Associate Director, Novartis
- Iris Bodenmann - Director, Cell Line Development, NewBiologix
- Yu-Tsan (Richard) Liu - Sr. Scientist, UCB Pharma
- Marija Brgles - Principal Scientist, Therapeutic Virus Development, Boehringer Ingelheim
- Rundown from the week’s content and learnings:
- Regulatory Updates: navigating the latest EMA and MHRA Guidelines
- Addressing the Evolving Landscape of CDMOs and Pharma Companies
- CDMO Perspectives: Insights on Outsourcing Downstream Processing
- Best Practices: Sharing Knowledge and Expertise for Optimized Processes
- The Future of Downstream Processing: Trends, Innovations, and Challenges
- Cost considerations In downstream processing: optimizing for efficiency and profitability.
- Ben Weil - Director of Manufacturing, INmune Bio
Overcoming logistical and regulatory challenges
Cost reduction without compromising on quality
Opening conversations with regulators and healthcare hubs to capitalise on this expertise
- Regional differences (nationalised vs. private healthcare systems)
Potential for point-of-care manufacturing to enable truly personalised cell therapies
- Omkar Kawalekar - Co-Founder, BlueWhale
- Ben Weil - Director of Manufacturing, INmune Bio
- Ben Weil - Director of Manufacturing, INmune Bio
Overcoming logistical and regulatory challenges
Cost reduction without compromising on quality
Opening conversations with regulators and healthcare hubs to capitalise on this expertise
- Regional differences (nationalised vs. private healthcare systems)
Potential for point-of-care manufacturing to enable truly personalised cell therapies
- Omkar Kawalekar - Co-Founder, BlueWhale
- Ben Weil - Director of Manufacturing, INmune Bio